Argen-X

Webpage: www.argen-x.com

General description
arGEN-X is a publically traded therapeutic antibody biotechnology company. We have a proprietary SIMPLE AntibodyTM discovery platform that allows us to discover high affinity, high diversity antibody sets covering essentially all epitopes of a given target. arGEN-X combines active immunisation of llamas with Fab phage display to induce and harvest conventional antibody output of the immune response. In addition to the antibody discovery platform arGEN-X has three Fc modulation technologies: PK enhancement through NHance; Abdeg technology for driving autoimmune antibodies into destruction and finally arGEN-X has a licence for the PotelligentTM technology which can significantly enhance antibody dependent cytotoxicity and tumour cell killing activity.

Key research facilities, infrastructures and equipment
760m2 lab space, equipped with two BiaCore 3000 instruments, FACS machine, AKTA Purifier Llama immunisations are performed off-site under supervision of arGEN-X employees or consultants.

Project members  

  • Dr. Hans de Haard
  • Drs. Michael Saunders 

Follow us on

ONCORNET2.0 Follow

ONCOgenic GPCR Network of Excellence and Training. An #EU Marie-Curie ITN of 16 Early Stage Researchers studying CXCR4 and ACKR3 #chemokine #GPCRs in cancer

Avatar
Avatar ONCORNET2.0 @oncornet1 ·
5 Nov

Great way to finish the week off with some #FCS measurements of CXCR4-expressing HEK cells at @UoNLifeSci 🔬 #FluorescenceFriday

Reply on Twitter 1456685143146500096 Retweet on Twitter 1456685143146500096 Like on Twitter 1456685143146500096 9 Twitter 1456685143146500096
Avatar ONCORNET2.0 @oncornet1 ·
20 Oct

Hello everyone!
I am Noemi Karsai and I’m the next in our #ESR introduction series. I’m #ESR11 and I’m originally from Hungary, currently doing my PhD at @UoNLifeSci @COMPARE_UoBUoN, UK.

Reply on Twitter 1450838316912455687 Retweet on Twitter 1450838316912455687 3 Like on Twitter 1450838316912455687 15 Twitter 1450838316912455687
Avatar ONCORNET2.0 @oncornet1 ·
8 Jul 2021

The transatlantic ECI GPCR symposium #ECIGPCR is about to start, we are ready!! Thanks to the organizers for their excellent job gathering almost 500 people across the globe! @cyclic_Andreas @NicoleAPerry1 @BenderSci @DesislavaNeshe1

Reply on Twitter 1413138789736730624 Retweet on Twitter 1413138789736730624 2 Like on Twitter 1413138789736730624 15 Twitter 1413138789736730624
Avatar ONCORNET2.0 @oncornet1 ·
29 Jun 2021

Hello 🙂
I am here to continue the series in which all #ESRs are presenting themselves. I am Viviana Marolda and I am in my first year of PhD. I am #ESR13, originally from Italy, and currently, I am working as a PhD student in @CBMSO_CSIC_UAM, at Universidad Autonoma de Madrid.

Reply on Twitter 1409799805195411457 Retweet on Twitter 1409799805195411457 1 Like on Twitter 1409799805195411457 11 Twitter 1409799805195411457
Avatar ONCORNET2.0 @oncornet1 ·
14 Jun 2021

Hey twitter!
I am @DehanComez. I am taking over the Oncornet account for a while to start a series of all #ESRs writing about themselves and their projects. I am #ESR5, originally from Turkey and right now I am working as a PhD student in @COMPARE_UoBUoN , @UniofNottingham , UK.

Reply on Twitter 1404396861121863681 Retweet on Twitter 1404396861121863681 4 Like on Twitter 1404396861121863681 38 Twitter 1404396861121863681
Retweet on Twitter ONCORNET2.0 Retweeted
Avatar David Gloriam @david_gloriam ·
28 May 2021

New review on #gpcr structural dynamics out in COSB. Great teamwork with the @JanaSelent group. Thanks to @Lundbeckfonden and @novonordiskfond https://lnkd.in/eyjrA5V

Reply on Twitter 1398230218188496901 Retweet on Twitter 1398230218188496901 2 Like on Twitter 1398230218188496901 13 Twitter 1398230218188496901
Avatar ONCORNET2.0 @oncornet1 ·
28 May 2021

ONCORNET2.0 is the successor to #ONCORNET. You can see some of the work of ESRs from the first ONCORNET in this special issue of @MolPharmJournal from 2019, with reviews on #CXCR4 and #ACKR3 structure and function: https://molpharm.aspetjournals.org/content/96/6

Reply on Twitter 1398237499756003329 Retweet on Twitter 1398237499756003329 1 Like on Twitter 1398237499756003329 3 Twitter 1398237499756003329
Avatar ONCORNET2.0 @oncornet1 ·
28 May 2021

Hi everyone – we’re on Twitter! ONCORNET2.0 is a #MarieCurie ITN of 16 ESRs across Europe studying #chemokine #GPCRs #CXCR4 and #ACKR3 in cancer. Our projects cover molecular dynamics, medchem, #pharmacology through to translational work. Follow us for updates from our ESRs!

Reply on Twitter 1398206898764140544 Retweet on Twitter 1398206898764140544 4 Like on Twitter 1398206898764140544 17 Twitter 1398206898764140544
Load More

Contact details

Please contact us at:
info@oncornet.eu

ONCORNET Coordinator
VU University Amsterdam
The Netherlands

Funded by

Marie Curie Actions

EU Horizon 2020

European Union